LCID
Lucid Group, Inc.
LCID lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
PSNY
Polestar Automotive Holding UK PLC
There isn't enough reported data to score PSNY yet.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
PSNY Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Stable |
PSNY's balance sheet is currently stable, but its profitability is weak. There isn't enough data to rate its revenue and cash flow.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
PSNY PE Valuation
PSNY has no meaningful PE right now: it lost money over the past year.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
PSNY Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Decline | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect PSNY's losses to grow, with revenue declining.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
PSNY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2023 | -$16.80 | -$9.90 |
PSNY and LCID do not have enough comparable growth data to identify a winner.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
PSNY has the stronger quarterly revenue trend. Revenue is up 4.1% for LCID versus up 16% for PSNY.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
PSNY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2025 | $1.4B | +57% |
| Q4 2024 | $1.1B | -0.2% |
| Q2 2024 | $905.8M | -26% |
| Q4 2023 | $1.1B | -54% |
| Q4 2022 | $2.5B | +318% |
| Q4 2021 | $589.5M | +100% |
| Q3 2021 | $212.9M | -28% |
| Q2 2021 | $267.4M | +2573% |
PSNY's revenue is recovering but still below its 2022 peak: $1.4B last quarter, up 16% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2025 | -77% | -52 points |
| Q4 2024 | -120% | -101 points |
| Q2 2024 | -51% | +5.9 points |
| Q4 2023 | -86% | +52 points |
| Q2 2023 | -25% | -25 points |
| Q4 2022 | -18% | -18 points |
| Q4 2021 | -57% | -57 points |
| Q3 2021 | -138% | -98 points |
PSNY's operating margin was −77% last quarter, down 52 points from the same quarter a year ago.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has the stronger cash trend. Its trailing FCF is down 75% versus its history, compared with PSNY at down 120%.
PSNY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2025 | -$585.7M | -$332.1M |
| Q4 2024 | -$885.6M | +$442.5M |
| Q2 2024 | -$253.5M | +$450.1M |
| Q4 2023 | -$1.3B | -$212.4M |
| Q4 2022 | -$1.1B | -$901.1M |
| Q4 2021 | -$214.6M | -1961% |
| Q3 2021 | -$55.5M | -581% |
| Q2 2021 | -$8.3M | +$56.5M |
PSNY has burned cash in almost every quarter: −$3.1B over the past year, against −$2.1B the year before.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
PSNY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +163K shares |
| 1 year | 0% | -14.9K shares |
PSNY has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
PSNY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2021 | 2.6x | Moderate |
PSNY's net debt is about 2.6 years of its operating earnings (EBITDA).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
PSNY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 26.9 | Oversold |
| Stochastic | 8.4 | Oversold |
PSNY's weekly RSI is 27 (oversold) and its Stochastic is 8 (oversold).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
PSNY PE vs Consumer Cyclical Sector
PSNY has no meaningful PE right now: it lost money over the past year.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
PSNY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.83 | 12% below |
| 20 week MA | $10.0 | 57% below |
| 50 week MA | $15.2 | 72% below |
| 100 week MA | $22.9 | 81% below |
| 200 week MA | $47.9 | 91% below |
PSNY is in a downtrend: it's below all five of its weekly moving averages, and 91% below its 200-week average.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has the edge over PSNY on returns for 2026, with the stronger performance.
PSNY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $292.8 | $346.5 | +18% |
| 2022 | $346.5 | $146.4 | -58% |
| 2023 | $146.4 | $67.8 | -54% |
| 2024 | $67.8 | $33.3 | -51% |
| 2025 | $33.3 | $17.5 | -47% |
| 2026 YTD | $17.5 | $4.26 | -76% |
PSNY has finished four years in a row lower, and it's down 76% so far in 2026.